IAP
KIDS icon

Indie Asset Partners’s OrthoPediatrics KIDS Stock Holding History

Indie Asset Partners’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,232
Closed -$212K – 132
2021
Q3 		$212K Hold
3,232
– – 0.17% 117
2021
Q2 		$204K Buy
+3,232
New +$186K 0.17% 120

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Indie Asset Partners's KIDS Position: Q4 2021 in Review

Indie Asset Partners sold out of OrthoPediatrics (KIDS) in Q4 2021, closing a stake of 3,232 shares — an estimated $212K sold.

Indie Asset Partners first reported a position in KIDS in Q2 2021 and held it in 2 quarters. The position peaked at $212K in Q3 2021. 131 funds tracked by Wall St. Rank hold KIDS as of Q4 2021.

  • Indie Asset Partners reported no remaining OrthoPediatrics position as of Q4 2021 after selling out during the quarter.
  • Indie Asset Partners sold 3,232 OrthoPediatrics shares in Q4 2021, an estimated $212K.
  • Indie Asset Partners first reported a position in OrthoPediatrics in Q2 2021 and held it in 2 quarters.
  • Indie Asset Partners's OrthoPediatrics position peaked at $212K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2021.

Based on Indie Asset Partners's 13F filing for Q4 2021, filed 11 Feb 2022.